Antisense oligonucleotides which reduce expression of the FGFRI gene
US5783683A · kind A · utility
35Cited by
1References
6Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 10, 1995 |
| Grant date | Jul 21, 1998 |
| Priority date | — |
| Expiry date | Jan 10, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/315
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antisense molecules, compositions thereof, and vectors encoding antisense RNA, and methods of using antisense molecules, compositions, and vectors for treating human glioblastoma cells in order to suppress the growth of the cells. The antisense molecules are substantially complementary to human fibroblast growth factor receptor gene one (the FGFR1).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.